Guangzhou Hospital Affiliated to the US and China (02453.HK) was granted 1.3 billion yuan in non-revolving credit

Gelonghui, May 20, 丨 US-China Jiahe (02453.HK) announced that on May 20, 2024, the company's subsidiary Guangzhou Taihe Cancer Hospital Co., Ltd. (“Guangzhou Hospital”) has signed a credit line agreement with the Beijing Branch of Shanghai Pudong Development Bank. Based on this, SPD Bank agreed to grant a non-revolving credit of up to RMB 1.3 billion to Guangzhou Hospital. The withdrawal period of this amount is one year, and the term of a single loan shall not exceed ten years. It is subject to and subject to the terms and conditions of various relevant specific agreements between Guangzhou Hospital and SPD Bank from time to time.

Gelonghui FinanceMay 20 10:11 ET

Concord Healthcare Updates Partnership, Disposal of Interests Terms

MT NewswiresMay 15 02:42 ET

Yoshikazu US and China (02453) proposed implementing full circulation of H shares

According to the Zhitong Finance App, the US and China Jiahe (02453) announced that the company submitted an application to the China Securities Regulatory Commission on April 30, 2024 to convert some domestic shares with a face value of RMB 1.00 per share of companies issued abroad to H shares with a face value of RMB 1.00 per share of companies listed on the main board of the Stock Exchange. After obtaining all relevant approvals (including filing and/or approval with the China Securities Regulatory Commission and the Stock Exchange) and complying with all applicable laws, regulations and rules, these domestic shares will be converted to H shares, and the company will apply for listing and trading of these H shares on the main board of the Stock Exchange. On the date of this announcement

Zhitong FinanceApr 30 04:33 ET

Yoshikazu America and China (02453.HK) set up three partnerships with independent third parties to seek long-term strategic development opportunities

Gelonghui, April 26, 丨 US and China Jiahe (02453.HK) announced that in order to promote the company's strategic development and business operation needs, the company and an independent third party set up three partnerships to manage minority shares in the three subsidiaries (i.e. Shanghai Hospital, Shanghai Outpatient Department and Ningbo Jiahe) acquired by the independent third party as a general partner to seek strategic opportunities in line with the company's long-term development. The relevant details are as follows: On April 7, 2024, April 22, 2024, and April 7, 2024, the company and Lingbou Private Equity (independent third party) were established, respectively Joined the partnership Jiaxue Health,

Gelonghui FinanceApr 26 10:32 ET

美中嘉和：2023年年報

Hong Kong Stock ExchangeApr 19 08:30 ET · Announcements

Changes in Hong Kong stocks | US-China Jiahe (02453) rose more than 17% in the afternoon to hit a new high of listing, annual revenue increased 14.1% year-on-year to $539 million

The Zhitong Finance App learned that the US and China Jiahe (02453) rose more than 17% in the afternoon to a high of HK$27.05, a record high. As of press release, it rose 13.7% to HK$26.15, with a turnover of HK$2,410,500. According to the news, the US and China Jiahe previously announced annual results, with revenue of 539 million yuan, up 14.1% year on year; the Group's hospital business revenue increased 46.5% year over year to 320 million yuan, mainly due to increased brand awareness and continued growth in medical demand. According to reports, medical institutions under the Group have achieved remarkable results in various fields. especially in tumors

Zhitong FinanceApr 15 01:36 ET